fda approves first oral glp-1 obesity drug august 14 2025 Pill Helped People With Lose Almost 30 Pounds in New Trial πNew GLP-1 pill gets FDA
Description
Article in the comments #GLP1 #FoodTrends #ConsumerBehavior #CulturalListening #Innovation #Ozempic #TrendForecasting #FMCG #CPGMarketing #FutureOfFood | 12 comments on LinkedIn
Risk of bias: all four RCTs were rated low risk by RoB2 (with some concerns for open-label outcome ascertainment in three trials, a domain-specific issue that does not alter the overall RoB2 category from low)

Explore glp-1 peptides side effects in research models, from GI issues to rare risks, and learn how to manage them safely.
The question is: How will we afford it?

A two-step MR analysis was further employed to explore potential mediating factors in the T2D-SA relationship